BioTech Holdings Announces First Clinical Use of Microbiome Optimized Autologous Stem Cells – PR Newswire (press release)
|
BioTech Holdings Announces First Clinical Use of Microbiome Optimized Autologous Stem Cells
PR Newswire (press release) SAN DIEGO, July 7, 2017 /PRNewswire/ — BioTech Holdings announced today clinical safety data on 3 patients suffering from critical limb ischemia treated with the Company's Procell microbiome-optimized personalized stem cell product. In the … |
